One such RNA-bindingprotein that regulates the most prevalent eukaryotic RNA modification, N6-methyladenosine (m6A), is the methyltransferase-likeprotein 16 (METTL16), which plays an oncogenic role in cancers bycofunctioning with other nucleic acid-binding proteins. Here, METTL16 is linked to cancer.